Tissue transglutaminase-mediated chemoresistance in cancer cells

作者: Amit Verma , Kapil Mehta

DOI: 10.1016/J.DRUP.2007.06.002

关键词: Cell migrationCancer stem cellSuicide geneMetastasisCell growthPI3K/AKT/mTOR pathwayCancer cellAngiogenesisCell biologyCancer researchBiology

摘要: Drug resistance and metastasis are major impediments for the successful treatment of cancer. A common feature among drug resistant metastatic tumor cells is that they exhibit profound to apoptosis. This property enables cancer not only grow survive in stressful environments (metastasis) but also display against many anticancer agents. Therefore, perturbation intrinsic apoptotic pathways will affect their ability respond chemotherapy metastasize distant sites. Recent studies have demonstrated cell lines selected chemotherapeutic drugs or isolated from sites, express elevated levels multifunctional protein, tissue transglutaminase (TG2). TG2 most diverse ubiquitous member family proteins implicated play a role apoptosis, wound healing, migration, attachment, growth, angiogenesis, matrix assembly. can associate with certain beta members integrin (beta1, beta3, beta4, beta5) promote stable interaction between extracellular (ECM), resulting increased survival, invasion. Additionally, forms ternary complex IkappaB/p65:p50 results constitutive activation nuclear transcription factor-kappaB (NF-kappaB). Moreover, expression leads focal adhesion kinase (FAK) its downstream PI3K/Akt survival pathway. Importantly, inhibition endogenous by small interfering RNA (siRNA) resulted reversal invasive phenotype. Conversely, ectopic promoted motility functions cells. review discusses current thinking implications development

参考文章(77)
Ugur Akar, Bulent Ozpolat, Kapil Mehta, Jansina Fok, Yasuko Kondo, Gabriel Lopez-Berestein, Tissue Transglutaminase Inhibits Autophagy in Pancreatic Cancer Cells Molecular Cancer Research. ,vol. 5, pp. 241- 249 ,(2007) , 10.1158/1541-7786.MCR-06-0229
Jansina Y. Fok, Suhendan Ekmekcioglu, Kapil Mehta, Implications of tissue transglutaminase expression in malignant melanoma Molecular Cancer Therapeutics. ,vol. 5, pp. 1493- 1503 ,(2006) , 10.1158/1535-7163.MCT-06-0083
Steffan T. Nawrocki, Jennifer S. Carew, Maria S. Pino, Ralph A. Highshaw, Kenneth Dunner, Peng Huang, James L. Abbruzzese, David J. McConkey, Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis Cancer Research. ,vol. 65, pp. 11658- 11666 ,(2005) , 10.1158/0008-5472.CAN-05-2370
Jongmin Lee, Yoon-Seong Kim, Dong-Hee Choi, Moon Suk Bang, Tai Ryoon Han, Tong H. Joh, Soo-Youl Kim, Transglutaminase 2 Induces Nuclear Factor-κB Activation via a Novel Pathway in BV-2 Microglia Journal of Biological Chemistry. ,vol. 279, pp. 53725- 53735 ,(2004) , 10.1074/JBC.M407627200
Francisca Vazquez, Shivapriya Ramaswamy, Noriaki Nakamura, William R. Sellers, Phosphorylation of the PTEN Tail Regulates Protein Stability and Function Molecular and Cellular Biology. ,vol. 20, pp. 5010- 5018 ,(2000) , 10.1128/MCB.20.14.5010-5018.2000
Dae-Seok Kim, Sung-Soo Park, Byung-Ho Nam, In-Hoo Kim, Soo-Youl Kim, Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-κB Inactivation Cancer Research. ,vol. 66, pp. 10936- 10943 ,(2006) , 10.1158/0008-5472.CAN-06-1521
Alex A. Adjei, Novel Combinations Based on Epidermal Growth Factor Receptor Inhibition: Fig. 1. Clinical Cancer Research. ,vol. 12, pp. 4446s- 4450s ,(2006) , 10.1158/1078-0432.CCR-06-0623
Jianyong Chen, Zaneta Nikolovska-Coleska, Guoping Wang, Su Qiu, Shaomeng Wang, Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein Bioorganic & Medicinal Chemistry Letters. ,vol. 16, pp. 5805- 5808 ,(2006) , 10.1016/J.BMCL.2006.08.072
Vincent Bours, Emmanuel Dejardin, Francine Goujon-Letawe, Marie-Paule Merville, Vincent Castronovo, The Nf-Kappa B Transcription Factor and Cancer: High Expression of Nf-Kappa B- and I Kappa B-Related Proteins in Tumor Cell Lines Biochemical Pharmacology. ,vol. 47, pp. 145- 149 ,(1994) , 10.1016/0006-2952(94)90448-0
Gordon W. McLean, Neil O. Carragher, Egle Avizienyte, Jeff Evans, Valerie G. Brunton, Margaret C. Frame, The role of focal-adhesion kinase in cancer — a new therapeutic opportunity Nature Reviews Cancer. ,vol. 5, pp. 505- 515 ,(2005) , 10.1038/NRC1647